Trademark: 76351863
Word
OXIGENE
Status Date
Tuesday, May 25, 2021
Registration Number
2697427
Registration Date
Tuesday, March 18, 2003
Filing Date
Friday, December 21, 2001
Published for Opposition
Tuesday, December 24, 2002
Cancellation Date
Tuesday, May 25, 2021
42 Cancer research; research and development of biopharmaceutical products, namely, vascular targeting agents and cancer therapies; and licensing of intellectual property in the field of biopharmaceutical compounds for vascular targeting agents and cancer therapies
In the statement, Column 2, line 3, "THE VASCULAR TARGETING COMPANY" is deleted, and the drawing is amended to appear as follows: PUBLISH CUT
May 25, 2021
Cancelled Section 18-Total
May 25, 2021
Cancellation Terminated No. 999999
May 24, 2021
Cancellation Granted No. 999999
Jan 25, 2021
Cancellation Instituted No. 999999
Jul 11, 2013
Notice Of Acceptance Of Sec. 8 & 9 - Mailed
Jul 11, 2013
Registered And Renewed (First Renewal - 10 Yrs)
Jul 11, 2013
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jul 11, 2013
Case Assigned To Post Registration Paralegal
Jul 1, 2013
Teas Section 8 & 9 Received
Apr 17, 2013
Amendment Under Section 7 ¿ Processed
Apr 3, 2013
Teas Section 7 Request Received
May 13, 2010
Applicant/Correspondence Changes (Non-Responsive) Entered
May 13, 2010
Teas Change Of Owner Address Received
Mar 16, 2009
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Mar 9, 2009
Assigned To Paralegal
Mar 5, 2009
Teas Section 8 & 15 Received
Mar 5, 2009
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 5, 2009
Teas Change Of Owner Address Received
Jun 16, 2008
Case File In Ticrs
Mar 18, 2003
Registered-Principal Register
Dec 24, 2002
Published For Opposition
Dec 4, 2002
Notice Of Publication
Oct 9, 2002
Approved For Pub - Principal Register
Sep 13, 2002
Correspondence Received In Law Office
Sep 13, 2002
Paper Received
Jun 28, 2002
Non-Final Action Mailed
Jun 26, 2002
Assigned To Examiner
Mar 19, 2002
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
